Servier India introduces ‘Ivosidenib’(Tibsovo®), in India, First-in-class Targeted Therapy in Oncology

Chennai, June 2025 Servier India, a subsidiary of the leading French pharmaceutical Servier Group, announced the launch ofIvosidenib (Tibsovo®), an oral targeted therapy approved in the management of cancer patients with Acute Myeloid Leukemia (AML) and Cholangiocarcinoma, with an isocitrate dehydrogenase-1 (IDH1) mutation. Servier

Read More

GEM Hospital’s SCOPE2025 – International Conference& Workshop on Advanced Therapeutic EndoscopySets New Standards in Gastrointestinal Care

Chennai 2025: The Department of Advanced Therapeutic Endoscopy and Gastroenterology at GEM Hospital(pioneers in minimally invasive surgery – laparoscopic & robotic surgeries) Chennai, proudly hosted SCOPE2025, a three-day international conference focused on

Read More

1 10 11 12 13 14 36